Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury.

Sapru A, Curley MA, Brady S, Matthay MA, Flori H.

Intensive Care Med. 2010 Jan;36(1):157-63. doi: 10.1007/s00134-009-1690-2. Epub 2009 Oct 24.

2.

Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials.

Agrawal A, Zhuo H, Brady S, Levitt J, Steingrub J, Siegel MD, Soto G, Peterson MW, Chesnutt MS, Matthay MA, Liu KD.

Am J Physiol Lung Cell Mol Physiol. 2012 Oct 15;303(8):L634-9. doi: 10.1152/ajplung.00195.2012. Epub 2012 Aug 3.

3.

Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury.

Prabhakaran P, Ware LB, White KE, Cross MT, Matthay MA, Olman MA.

Am J Physiol Lung Cell Mol Physiol. 2003 Jul;285(1):L20-8. Epub 2003 May 2.

4.

The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS.

Tsangaris I, Tsantes A, Bonovas S, Lignos M, Kopterides P, Gialeraki A, Rapti E, Orfanos S, Dimopoulou I, Travlou A, Armaganidis A.

Thromb Res. 2009 Apr;123(6):832-6. doi: 10.1016/j.thromres.2008.07.018. Epub 2008 Sep 20.

PMID:
18804848
5.

Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury.

McClintock D, Zhuo H, Wickersham N, Matthay MA, Ware LB.

Crit Care. 2008;12(2):R41. doi: 10.1186/cc6846. Epub 2008 Mar 21.

6.

The effect of plasma homocysteine levels on clinical outcomes of patients with acute lung injury/acute respiratory distress syndrome.

Tsangaris I, Tsantes A, Bagos P, Nikolopoulos G, Kroupis C, Kopterides P, Dimopoulou I, Orfanos S, Kardoulaki A, Chideriotis S, Travlou A, Armaganidis A.

Am J Med Sci. 2009 Dec;338(6):474-7. doi: 10.1097/MAJ.0b013e3181b97c00.

PMID:
20010155
7.

Early elevations in B-type natriuretic peptide levels are associated with poor clinical outcomes in pediatric acute lung injury.

Reel B, Oishi PE, Hsu JH, Gildengorin G, Matthay MA, Fineman JR, Flori H.

Pediatr Pulmonol. 2009 Nov;44(11):1118-24. doi: 10.1002/ppul.21111.

8.

Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome.

Ware LB, Matthay MA, Parsons PE, Thompson BT, Januzzi JL, Eisner MD; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network.

Crit Care Med. 2007 Aug;35(8):1821-8.

10.

Blood product transfusions and clinical outcomes in pediatric patients with acute lung injury.

Church GD, Matthay MA, Liu K, Milet M, Flori HR.

Pediatr Crit Care Med. 2009 May;10(3):297-302. doi: 10.1097/PCC.0b013e3181988952.

11.

Plasma granulocyte colony-stimulating factor levels correlate with clinical outcomes in patients with acute lung injury.

Suratt BT, Eisner MD, Calfee CS, Allard JB, Whittaker LA, Engelken DT, Petty JM, Trimarchi T, Gauthier L, Parsons PE; NHLBI Acute Respiratory Distress Syndrome Network.

Crit Care Med. 2009 Apr;37(4):1322-8. doi: 10.1097/CCM.0b013e31819c14fa.

12.

Association between C-reactive protein levels and outcome in acute lung injury in children.

Bruijn M, Jansen EM, Klapwijk T, van der Lee JH, van Rijn RR, van Woensel JB, Bos AP.

Eur J Pediatr. 2013 Aug;172(8):1105-10. doi: 10.1007/s00431-013-2006-7. Epub 2013 May 3.

PMID:
23640022
13.

The role of bronchoalveolar hemostasis in the pathogenesis of acute lung injury.

Hofstra JJ, Haitsma JJ, Juffermans NP, Levi M, Schultz MJ.

Semin Thromb Hemost. 2008 Jul;34(5):475-84. doi: 10.1055/s-0028-1092878. Epub 2008 Oct 27. Review.

PMID:
18956288
14.

Alveolar Dead Space Fraction Discriminates Mortality in Pediatric Acute Respiratory Distress Syndrome.

Yehya N, Bhalla AK, Thomas NJ, Khemani RG.

Pediatr Crit Care Med. 2016 Feb;17(2):101-9. doi: 10.1097/PCC.0000000000000613.

15.

Randomized clinical trial of activated protein C for the treatment of acute lung injury.

Liu KD, Levitt J, Zhuo H, Kallet RH, Brady S, Steingrub J, Tidswell M, Siegel MD, Soto G, Peterson MW, Chesnutt MS, Phillips C, Weinacker A, Thompson BT, Eisner MD, Matthay MA.

Am J Respir Crit Care Med. 2008 Sep 15;178(6):618-23. doi: 10.1164/rccm.200803-419OC. Epub 2008 Jun 19.

16.

Keratinocyte growth factor expression is suppressed in early acute lung injury/acute respiratory distress syndrome by smad and c-Abl pathways.

Chandel NS, Budinger GR, Mutlu GM, Varga J, Synenki L, Donnelly HK, Zirk A, Eisenbart J, Jovanovic B, Jain M.

Crit Care Med. 2009 May;37(5):1678-84. doi: 10.1097/CCM.0b013e31819fc81a.

PMID:
19325470
17.

SuPAR and PAI-1 in critically ill, mechanically ventilated patients.

Jalkanen V, Yang R, Linko R, Huhtala H, Okkonen M, Varpula T, Pettilä V, Tenhunen J; FINNALI Study Group.

Intensive Care Med. 2013 Mar;39(3):489-96. doi: 10.1007/s00134-012-2730-x. Epub 2012 Oct 26.

PMID:
23100007
18.

Suppression of plasminogen activator inhibitor-1 by inhaled nitric oxide attenuates the adverse effects of hyperoxia in a rat model of acute lung injury.

Chen Y, Lu ZJ, Yang Y, Lu GP, Chen WM, Zhang LE.

Thromb Res. 2015 Jul;136(1):131-8. doi: 10.1016/j.thromres.2015.04.018. Epub 2015 Apr 22.

PMID:
25934465
19.

Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury.

Calfee CS, Eisner MD, Parsons PE, Thompson BT, Conner ER Jr, Matthay MA, Ware LB; NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network.

Intensive Care Med. 2009 Feb;35(2):248-57. doi: 10.1007/s00134-008-1235-0. Epub 2008 Aug 1. Review.

20.

Supplemental Content

Support Center